MORGAN STANLEY PLC/CALL/ECKERT & ZIEGLER/46/0.1/20.09.24 | Real-time Bid/Ask 09:35:53 2024-06-26 EDT | ||
| 0.51 EUR / 0.56 EUR | -6.14% |
|
| Current month | +42.50% | ||
| 1 month | +26.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ECKERT & ZIEGLER SE
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 0.51 | -10.53% |
| 24-06-25 | 0.57 | +62.86% |
| 24-06-24 | 0.35 | +2.94% |
| 24-06-21 | 0.34 | -8.11% |
| 24-06-20 | 0.37 | +23.33% |
Delayed Quote Börse Stuttgart
Last update June 26, 2024 at 08:00 am
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ECKERT & ZIEGLER SE |
| Issuer | Morgan Stanley |
| WKN | ME4V2K |
| ISIN | DE000ME4V2K7 |
| Date issued | 2023-12-07 |
| Strike | 46 € |
| Maturity | 2024-09-20 (86 Days) |
| Parity | 10 : 1 |
| Emission price | 0.08 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.87 € |
|---|---|
| Lowest since issue | 0.107 € |
| Delta | 0.63x |
| Omega | 5.505 |
| Premium | 7.41x |
| Gearing | 8.79x |
| Moneyness | 1.041 |
| Difference Strike | -1.99 € |
| Difference Strike % | -4.33% |
| Spread | 0.05 € |
| Spread % | 8.77% |
| Theoretical value | 0.5450 |
| Implied Volatility | 46.93 % |
| Total Loss Probability | 46.16 % |
| Intrinsic value | 0.1900 |
| Present value | 0.3550 |
| Break even | 51.45 € |
| Theta | -0.02x |
| Vega | 0.01x |
| Rho | 0.01x |
Company Profile
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Sector
-
Consensus: Eckert & Ziegler SE
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
48.88
EUR
Average target price
62.5
EUR
Spread / Average Target
+27.86%
- Stock Market
- Warrants
- Warrant
